■VisuALLS是一个自动的,静态阈值,基于虚拟现实的边界,用于视野的移动评估。我们检查了同一天和3个月的可重复性。
■诊断为青光眼或高眼压症的成年参与者在基线时接受了两次VisuALL24-2正常T-全阈值策略测试,并在3个月时对每只合格的眼睛进行了一次额外检查。斯皮尔曼,类内相关系数(ICC),和Bland-Altman图用于评估三个测试中单个点敏感性和平均偏差(MD)的相关性。
■包括88只眼睛(44名参与者)。平均年龄为68.1±14.3岁,60.7%为男性。VisuALLMD在测试之间高度相关(内部检查:r=0.89,访问:r=0.82;两者均P<0.001)。Bland-Altman分析显示,体内MD的平均差异为-0.67dB(95%置信区间[CI],-6.04至4.71dB)和-0.15dB(95%CI,-8.04至7.73dB),用于互访考试。百分之八五的点状体内ICC高于0.75(范围,0.63至0.93),65%的逐点互访ICC高于0.75(范围,0.55至0.91)。
■VisuALL证明了测试之间的MD高度相关,并且在3个月的三个测试中,单个点敏感性具有良好的可重复性,除了在盲点周围和上级的地方。
■VisuALL的初步再现性结果令人鼓舞。其便携式设计使其成为青光眼患者的潜在有用工具,能够在家庭和临床环境中进行更频繁的评估。
UNASSIGNED: The VisuALL S is an automated, static threshold, virtual reality-based perimeter for mobile evaluation of the visual field. We examined same-day and 3-month repeatability.
UNASSIGNED: Adult participants with a diagnosis of glaucoma or ocular hypertension underwent two VisuALL 24-2 Normal T- Full threshold strategy tests at baseline and one additional exam at 3 months for each eligible eye. Spearman, intraclass correlation coefficients (ICCs), and Bland-Altman plots were used to assess the correlation of individual point sensitivities and mean deviation (MD) among three tests.
UNASSIGNED: Eighty-eight eyes (44 participants) were included. Average age was 68.1 ± 14.3 years, and 60.7% were male. VisuALL MD was highly correlated between tests (intravisit: r = 0.89, intervisit: r = 0.82; P < 0.001 for both). Bland-Altman analysis showed an average difference in intravisit MD of -0.67 dB (95% confidence interval [CI], -6.04 to 4.71 dB) and -0.15 dB (95% CI, -8.04 to 7.73 dB) for intervisit exams. Eight-five percent of pointwise intravisit ICCs were above 0.75 (range, 0.63 to 0.93), and 65% of pointwise intervisit ICCs were above 0.75 (range, 0.55 to 0.91).
UNASSIGNED: VisuALL demonstrated high correlation of MD between tests and good repeatability for individual point sensitivities among three tests in 3 months, except at the points around the blind spot and superiorly.
UNASSIGNED: The preliminary reproducibility results for VisuALL are encouraging. Its portable design makes it a potentially useful tool for patients with glaucoma, enabling more frequent assessments both at home and in clinical settings.